Performance of Different Diagnostic Criteria for Familial Mediterranean Fever in Children with Periodic Fevers: Results from a Multicenter International Registry
Authors:
- Erkan DemirkayaEDErkan Demirkaya
- Celal SaglamCSCelal Saglam
- Turker TurkerTTTurker Turker
- Isabelle Koné-PautIKIsabelle Koné-Paut
- Pat WooPWPat Woo
- Matteo DoglioMDMatteo Doglio
- Gayane AmaryanGAGayane Amaryan
- Joost FrenkelJFJoost Frenkel
- Yosef UzielYUYosef Uziel
- Antonella InsalacoAIAntonella Insalaco
- Luca CantariniLCLuca Cantarini
- Michael HoferMHMichael Hofer
- 15 November 2015
- journal article
- research article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 43 (1) , 154-160
Abstract
Objective.: Our aims were to validate the pediatric diagnostic criteria in a large international registry and to compare them with the performance of previous criteria for the diagnosis of familial Mediterranean fever (FMF).Methods.: Pediatric patients with FMF from the Eurofever registry were used for the validation of the existing criteria. The other periodic fevers served as controls: mevalonate kinase deficiency (MKD), tumor necrosis factor receptor–associated periodic syndrome (TRAPS), cryopyrin-associated periodic syndrome (CAPS), aphthous stomatitis, pharyngitis, adenitis syndrome (PFAPA), and undefined periodic fever from the same registry. The performances of Tel Hashomer, Livneh, and the Yalcinkaya-Ozen criteria were assessed.Results.: The FMF group included 339 patients. The control group consisted of 377 patients (53 TRAPS, 45 MKD, 32 CAPS, 160 PFAPA, 87 undefined periodic fevers). Patients with FMF were correctly diagnosed using the Yalcinkaya-Ozen criteria with a sensitivity rate of 87.4% and a specificity rate of 40.7%. On the other hand, Tel Hashomer and Livneh criteria displayed a sensitivity of 45.0 and 77.3%, respectively. Both of the latter criteria displayed a better specificity than the Yalcinkaya-Ozen criteria: 97.2 and 41.1% for the Tel Hashomer and Livneh criteria, respectively. The overall accuracy for the Yalcinkaya-Ozen criteria was 65 and 69.6% (using 2 and 3 criteria), respectively. Ethnicity and residence had no effect on the performance of the Yalcinkaya-Ozen criteria.Conclusion.: The Yalcinkaya-Ozen criteria yielded a better sensitivity than the other criteria in this international cohort of patients and thus can be used as a tool for FMF diagnosis in pediatric patients from either the European or eastern Mediterranean region. However, the specificity was lower than the previously suggested adult criteria.Keywords
This publication has 19 references indexed in Scilit:
- An International registry on Autoinflammatory diseases: the Eurofever experienceAnnals of the Rheumatic Diseases, 2012
- A Glance at History and Future Perspectives of Childhood Autoinflammatory DisordersAnnals of Paediatric Rheumatology, 2012
- Familial Mediterranean Fever in the WorldArthritis Care & Research, 2009
- Mutation frequency of Familial Mediterranean Fever and evidence for a high carrier rate in the Turkish populationEuropean Journal of Human Genetics, 2001
- Genotype–phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation-independent amyloidosisRheumatology, 2000
- MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean feverAmyloid, 1999
- Criteria for the diagnosis of familial mediterranean feverArthritis & Rheumatism, 1997
- Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean FeverCell, 1997
- Colchicine for Familial Mediterranean FeverNew England Journal of Medicine, 1972
- Familial Mediterranean feverThe American Journal of Medicine, 1967